Reiner Siebert

ORCID: 0000-0002-6492-5323
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Lymphoma Diagnosis and Treatment
  • Chronic Lymphocytic Leukemia Research
  • Chromatin Remodeling and Cancer
  • Cancer Genomics and Diagnostics
  • Cancer Mechanisms and Therapy
  • Viral-associated cancers and disorders
  • Epigenetics and DNA Methylation
  • RNA modifications and cancer
  • Genomic variations and chromosomal abnormalities
  • CAR-T cell therapy research
  • Acute Lymphoblastic Leukemia research
  • Chronic Myeloid Leukemia Treatments
  • Acute Myeloid Leukemia Research
  • CNS Lymphoma Diagnosis and Treatment
  • Gestational Trophoblastic Disease Studies
  • Immune Cell Function and Interaction
  • Genetic factors in colorectal cancer
  • Genomics and Chromatin Dynamics
  • Monoclonal and Polyclonal Antibodies Research
  • RNA Research and Splicing
  • Immunodeficiency and Autoimmune Disorders
  • Multiple Myeloma Research and Treatments
  • Protein Degradation and Inhibitors
  • Mechanisms of cancer metastasis
  • Cancer-related molecular mechanisms research

Universität Ulm
2016-2025

University Hospital Ulm
2016-2024

Robert Bosch Hospital
2024

University Medical Center
2019-2024

German Center for Pediatric and Adolescent Rheumatology
2024

Kiel University
2014-2023

University Hospital Schleswig-Holstein
2013-2023

University of Lübeck
2013-2023

University of Toronto
2020

University Hospital Cologne
2016

Claudia Calabrese Natalie R. Davidson Deniz Demircioğlu Nuno A. Fonseca Yao He and 95 more André Kahles Kjong-Van Lehmann Fenglin Liu Yuichi Shiraishi Cameron M. Soulette Lara Urban Claudia Calabrese Natalie R. Davidson Deniz Demircioğlu Nuno A. Fonseca Yao He André Kahles Kjong-Van Lehmann Fenglin Liu Yuichi Shiraishi Cameron M. Soulette Lara Urban Liliana Greger Siliang Li Dongbing Liu Marc D. Perry Qian Xiang Fan Zhang Junjun Zhang Peter J. Bailey Serap Erkek Katherine A. Hoadley Yong Hou Matthew R. Huska Helena Kilpinen Jan O. Korbel Maximillian G. Marin Julia Markowski Tannistha Nandi Qiang Pan‐Hammarström Chandra Sekhar Pedamallu Reiner Siebert Stefan G. Stark Hong Su Patrick Tan Sebastian M. Waszak Christina K. Yung Shida Zhu Philip Awadalla Chad J. Creighton Matthew Meyerson B. F. Francis Ouellette Kui Wu Huanming Yang Nuno A. Fonseca André Kahles Kjong-Van Lehmann Lara Urban Cameron M. Soulette Yuichi Shiraishi Fenglin Liu Yao He Deniz Demircioğlu Natalie R. Davidson Claudia Calabrese Junjun Zhang Marc D. Perry Qian Xiang Liliana Greger Siliang Li Dongbing Liu Stefan G. Stark Fan Zhang Samirkumar B. Amin Peter J. Bailey Aurélien Chateigner Isidro Cortés‐Ciriano Brian Craft Serap Erkek Milana Frenkel‐Morgenstern Mary J. Goldman Katherine A. Hoadley Yong Hou Matthew R. Huska Ekta Khurana Helena Kilpinen Jan O. Korbel Fabien C. Lamaze David K. Chang Xiaobo Li Xinyue Li Xingmin Liu Maximillian G. Marin Julia Markowski Tannistha Nandi Morten M. Nielsen Akinyemi I. Ojesina Qiang Pan‐Hammarström Peter J. Park Chandra Sekhar Pedamallu

Abstract Transcript alterations often result from somatic changes in cancer genomes 1 . Various forms of RNA have been described cancer, including overexpression 2 , altered splicing 3 and gene fusions 4 ; however, it is difficult to attribute these underlying genomic owing heterogeneity among patients tumour types, the relatively small cohorts for whom samples analysed by both transcriptome whole-genome sequencing. Here we present, our knowledge, most comprehensive catalogue...

10.1038/s41586-020-1970-0 article EN cc-by Nature 2020-02-05

DNA methylation patterns are altered in numerous diseases and often correlate with clinically relevant information such as disease subtypes, prognosis drug response. With suitable assays after validation large cohorts, associations can be exploited for clinical diagnostics personalized treatment decisions. Here we describe the results of a community-wide benchmarking study comparing performance all widely used methods analysis that compatible routine use. We shipped 32 reference samples to...

10.1038/nbt.3605 article EN cc-by-nc-sa Nature Biotechnology 2016-06-27

Atypical teratoid/rhabdoid tumors (AT/RTs) are highly aggressive brain of early childhood poorly responding to therapy. The majority cases show inactivation SMARCB1 (INI1, hSNF5, BAF47), a core member the adenosine triphosphate (ATP)-dependent SWI/SNF chromatin-remodeling complex. We here report case supratentorial AT/RT in 9-month-old boy, which showed retained staining on immunohistochemistry and lacked genetic alterations SMARCB1. Instead, tumor loss protein expression another complex...

10.1097/pas.0b013e3182196a39 article EN The American Journal of Surgical Pathology 2011-05-13
Josefine Radke Naveed Ishaque Randi Koll Zuguang Gu Elisa Schumann and 95 more Lina Sieverling Sebastian Uhrig Daniel Hübschmann Umut H. Toprak Cristina López Xavier Pastor Hostench Simone Borgoni Dilafruz Juraeva Fabienne Pritsch Nagarajan Paramasivam Gnana Prakash Balasubramanian Matthias Schlesner Shashwat Sahay Marc A. Weniger Debora Pehl Helena Radbruch Anja Osterloh Agnieszka Korfel Martin Misch Julia Onken Katharina Faust Peter Vajkoczy Dag Moskopp Yawen Wang Andreas Jödicke Lorenz Trümper Ioannis Anagnostopoulos Dido Lenze Ralf Küppers Michael Hummel Clemens A. Schmitt Otmar D. Wiestler Stephan Wolf Andreas Unterberg Roland Eils Christel Herold‐Mende Benedikt Brors Reiner Siebert Susanne Wagner Andrea Haake Julia Richter Gesine Richter Roland Eils Chris Lawerenz Roland Eils Jules N. A. Kerssemakers Christina Jaeger-Schmidt Ingrid Scholz Anke Bergmann Christoph Borst Friederike Braulke Birgit Burkhardt Alexander Claviez Martin Dreyling Sonja Eberth Hermann Einsele Norbert Frickhofen Siegfried Haas Martin‐Leo Hansmann Dennis Karsch Nicole Klepl Michael Kneba Jasmin Lisfeld Luisa Mantovani‐Löffler Marius Rohde German Ott Christina Stadler Peter Staib Stephan Stilgenbauer Thorsten Zenz Martin‐Leo Hansmann Dieter Kube Siegfried Haas Wolfram Klapper Ulrike Kostezka Peter Möller Andreas Rosenwald German Ott Monika Szczepanowski Ole Ammerpohl Sietse Aukema Vera Binder Arndt Borkhardt Andrea Haake Jessica I. Hoell Ellen Leich Peter Lichter Cristina López Inga Nagel Jordan Pischimariov Bernhard Radlwimmer Julia Richter Philip Rosenstiel Andreas Rosenwald Markus B. Schilhabel

Primary lymphomas of the central nervous system (PCNSL) are mainly diffuse large B-cell (DLBCLs) confined to (CNS). Molecular drivers PCNSL have not been fully elucidated. Here, we profile and compare whole-genome transcriptome landscape 51 CNS (CNSL) 39 follicular lymphoma 36 DLBCL cases outside CNS. We find recurrent mutations in JAK-STAT, NFkB, receptor signaling pathways, including hallmark MYD88 L265P (67%) CD79B (63%), CDKN2A deletions (83%). PCNSLs exhibit significantly more focal...

10.1038/s41467-022-30050-y article EN cc-by Nature Communications 2022-05-10

Circulating progenitor cells home to sites of postnatal neovascularization and differentiate into endothelial but questions remain regarding the source these cells. Indeed, a recent study suggests that nonbone marrow-derived may be even more important than bone in setting transplant arteriosclerosis. Thus, we aimed thoroughly investigate contribution for neovascularization. We exclusively identified by combining parabiosis model with reverse marrow transplantation followed hindlimb ischemia....

10.1161/01.res.0000259562.63718.35 article EN Circulation Research 2007-02-03

Chromosomal translocations affecting the MYC oncogene are biological hallmark of Burkitt lymphomas but also occur in a subset other mature B-cell lymphomas. If accompanied by chromosomal break targeting BCL2 and/or BCL6 these translocation-positive (MYC+) called double-hit lymphomas, otherwise term single-hit is applied. In order to characterize features MYC+ than lymphoma we explored, after exclusion molecular as defined gene expression profiling, molecular, pathological and clinical...

10.3324/haematol.2013.091827 article EN cc-by-nc Haematologica 2013-10-31

Abstract Atypical teratoid/rhabdoid tumor (AT/RT) is a rare malignant pediatric brain characterized by genetic alterations affecting the SMARCB1 ( hSNF5/INI1 ) locus in chromosome band 22q11.2. To identify potential additional alterations, high‐resolution genome‐wide analysis was performed using molecular inversion probe single‐nucleotide polymorphism (MIP SNP) assay (Affymetrix OncoScan formalin‐fixed paraffin‐embedded express) on DNA isolated from 18 archival samples. Alterations could be...

10.1002/gcc.22018 article EN Genes Chromosomes and Cancer 2012-10-17

The evolution and progression of multiple myeloma its precursors over time is poorly understood. Here, we investigate the landscape timing mutational processes shaping in a large cohort 89 whole genomes 973 exomes. We identify eight processes, including signature caused by exposure to melphalan. Reconstructing chronological activity each signature, estimate that initial transformation germinal center B-cell usually occurred during first 2

10.1038/s41467-020-15740-9 article EN cc-by Nature Communications 2020-04-21

Genomic imprinting results from the resistance of germline epigenetic marks to reprogramming in early embryo for a small number mammalian genes. Genetic, or environmental insults that prevent imprints evading may result disorders, which impact growth, development, behaviour and metabolism. We aimed identify genetic defects causing disorders by whole-exome sequencing families with one more members affected multilocus disturbance.Whole-exome was performed 38 pedigrees where probands had...

10.1136/jmedgenet-2017-105190 article EN cc-by Journal of Medical Genetics 2018-03-24
Constance H. Li Stephenie D. Prokopec Ren Sun Fouad Yousif Nathaniel Schmitz and 95 more Fátima Al‐Shahrour Gurnit Atwal Peter J. Bailey Andrew V. Biankin Paul C. Boutros Peter J. Campbell David K. Chang Susanna L. Cooke Vikram Deshpande Bishoy M. Faltas William C. Faquin Levi A. Garraway Gad Getz Sean M. Grimmond Syed Haider Katherine A. Hoadley Wei Jiao Vera B. Kaiser Rosa Karlić Mamoru Kato Kirsten Kübler Alexander J. Lazar Constance H. Li David N. Louis Jake Lin Sancha Martin Hardeep K. Nahal-Bose G. Petur Nielsen Serena Nik‐Zainal Larsson Omberg Christine P’ng Marc D. Perry Paz Polak Esther Rheinbay Mark A. Rubin Colin A. Semple Dennis C. Sgroi Tatsuhiro Shibata Reiner Siebert Jaclyn Smith Lincoln Stein Miranda D. Stobbe Ren Sun Kevin Thai Derek Wright Chin‐Lee Wu Ke Yuan Junjun Zhang Paul C. Boutros Lauri A. Aaltonen Federico Abascal Adam Abeshouse Hiroyuki Aburatani David J. Adams Nishant Agrawal Keun Soo Ahn Sung-Min Ahn Hiroshi Aikata Rehan Akbani Kadir C. Akdemir Hikmat Al‐Ahmadie Sultan T. Al‐Sedairy Fátima Al‐Shahrour Malik Alawi Monique Albert Kenneth Aldape Ludmil B. Alexandrov Adrian Ally Kathryn Alsop Eva G. Álvarez Fernanda Amary Samirkumar B. Amin Brice Aminou Ole Ammerpohl Matthew J. Anderson Yeng Ang Davide Antonello Pavana Anur Samuel Aparício Elizabeth L. Appelbaum Yasuhito Arai Axel Aretz Koji Arihiro Shun‐ichi Ariizumi Joshua Armenia Laurent Arnould L. Sylvia Yassen Assenov Gurnit Atwal Sietse Aukema J. Todd Auman Miriam R. R. Aure Philip Awadalla Marta Aymerich Gary D. Bader

Abstract Sex differences have been observed in multiple facets of cancer epidemiology, treatment and biology, most cancers outside the sex organs. Efforts to link these clinical specific molecular features focused on somatic mutations within coding regions genome. Here we report a pan-cancer analysis whole genomes 1983 tumours 28 subtypes as part ICGC/TCGA Pan-Cancer Analysis Whole Genomes (PCAWG) Consortium. We both confirm results exome studies, also uncover previously undescribed...

10.1038/s41467-020-17359-2 article EN cc-by Nature Communications 2020-08-28

Abstract Background Controversy exists as to what may be defined standard of care (including markers for stratification) patients with atypical teratoid/rhabdoid tumors (ATRTs). The European Rhabdoid Registry (EU-RHAB) recruits uniformly treated and offers standardized genetic DNA methylation analyses. Methods Clinical, genetic, treatment data 143 from 13 countries were analyzed (2009–2017). Therapy consisted surgery, anthracycline-based induction, either radiotherapy or high dose...

10.1093/neuonc/noz244 article EN Neuro-Oncology 2019-12-27

While survival has improved for Burkitt lymphoma patients, potential differences in outcome between pediatric and adult patients remain unclear. In both age groups, remains poor at relapse. Therefore, we conducted a comparative study large cohort, including 191 cases 97 samples from adults. TP53 CCND3 mutation frequencies are not related, showed higher frequency of mutations ID3, DDX3X, ARID1A SMARCA4, while several genes such as BCL2 YY1AP1 almost exclusively mutated patients. An unbiased...

10.1038/s41467-022-31355-8 article EN cc-by Nature Communications 2022-07-06

Abstract The fifth edition of the World Health Organization Classification Haematolymphoid Tumours (WHO‐HAEM5) is product an evidence‐based evolution revised fourth with wide multidisciplinary consultation. Nonetheless, while every classification incorporates scientific advances and aims to improve upon prior version, medical knowledge remains incomplete individual neoplasms may not be easily subclassified in a given scheme. Thus, optimal requires ongoing study, there are certain aspects...

10.1002/path.6246 article EN cc-by The Journal of Pathology 2024-01-05
Coming Soon ...